These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 665594)

  • 1. Recurrent mumps parotitis following natural infection and immunization.
    Biedel CW
    Am J Dis Child; 1978 Jul; 132(7):678-80. PubMed ID: 665594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral etiology of parotitis.
    Meurman O; Vainionpää R; Rossi T; Hänninen P
    Scand J Infect Dis; 1983; 15(2):145-8. PubMed ID: 6308753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parotitis in children who had previously received mumps vaccine.
    Brunell PA; Brickman A; Steinberg S; Allen E
    Pediatrics; 1972 Sep; 50(3):441-4. PubMed ID: 5056417
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay of mumps antibody for evaluation of immune status before and after vaccination.
    Kuno-Sakai H; Iwasaki H; Kimura M
    J Infect Dis; 1984 May; 149(5):813. PubMed ID: 6726005
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etiology of epidemic parotitis].
    Mihály I; Kukán E; Gellért M; Gerö A; Mándoky F
    Orv Hetil; 1994 Jan; 135(1):3-6. PubMed ID: 8290235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute parotitis in children previously vaccinated against mumps].
    Mihály I; Budai J; Gerö A; Kukán E
    Orv Hetil; 1994 Feb; 135(6):287-90. PubMed ID: 8309684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viruses detected among sporadic cases of parotitis, United States, 2009-2011.
    Barskey AE; Juieng P; Whitaker BL; Erdman DD; Oberste MS; Chern SW; Schmid DS; Radford KW; McNall RJ; Rota PA; Hickman CJ; Bellini WJ; Wallace GS
    J Infect Dis; 2013 Dec; 208(12):1979-86. PubMed ID: 23935203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological survey of parainfluenza and parotitis in the population of Czechoslovakia.
    Pecenková I; Tůmová B; Fedová D; Pecenka J
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):173-83. PubMed ID: 170333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae.
    Cooney MK; Fox JP; Hall CE
    Am J Epidemiol; 1975 Jun; 101(6):532-51. PubMed ID: 168766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against epidemic parotitis].
    Midulla M; Chiavelli S
    Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live vaccines.
    Norrby E; Penttinen K
    J Infect Dis; 1978 Nov; 138(5):672-6. PubMed ID: 712121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological standardization of a test for susceptibility to mumps.
    Shehab ZM; Brunell PA; Cobb E
    J Infect Dis; 1984 May; 149(5):810-2. PubMed ID: 6373967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory diagnosis of parotitis in the post-vaccination era].
    de la Loma A; Villota J; Varela JM; Alonso M; de Ory F
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):119-20. PubMed ID: 12586040
    [No Abstract]   [Full Text] [Related]  

  • 14. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.
    Mauldin J; Carbone K; Hsu H; Yolken R; Rubin S
    J Clin Microbiol; 2005 Sep; 43(9):4847-51. PubMed ID: 16145156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age distribution of the incidence and immune structure of the pediatric population in epidemic parotitis].
    Lazikova GF; Vardanian NV; Nikolaevskiĭ GP
    Vopr Virusol; 1979; (1):64-6. PubMed ID: 419741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of mumps vaccines and immunization of monkeys against experimental mumps infection.
    HABEL K
    Public Health Rep (1896); 1946 Nov; 61(46):1655-64. PubMed ID: 20341095
    [No Abstract]   [Full Text] [Related]  

  • 17. [An intranasal method of revaccination against mumps].
    Krasnova VP; Iuminova NV; Liashenko VA
    Vopr Virusol; 1994; 39(1):24-6. PubMed ID: 8160444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response following measles-mumps-rubella vaccine under conditions of customary use.
    Brunell PA; Weigle K; Murphy MD; Shehab Z; Cobb E
    JAMA; 1983 Sep; 250(11):1409-12. PubMed ID: 6887461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.
    Sakata R; Nagita A; Kidokoro M; Kato A; Ogino K
    Pediatr Res; 2015 Nov; 78(5):580-4. PubMed ID: 26267156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.